Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepavax-Gene in HIV-infected patients
NCT01289106Phase 3Unknown
- Sponsor
- Chiang Mai University
- Start
- Jan 2011
- Primary completion
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis b vaccine (recombinant) in hepatitis B (HBV), sponsored by Chiang Mai University. Status: unknown.
02
Drugs
hepatitis b vaccine (recombinant)
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01289106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289106.